Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Partial debridement is the most commonly reported treatment option for mucoid degeneration of the anterior cruciate ligament: a systematic review
by
Diao, Yi David
, Nagai, Kanto
, Kay, Jeffrey
, Hoshino, Yuichi
, de SA, Darren
, Vivekanantha, Prushoth
in
Anterior cruciate ligament
/ Anterior Cruciate Ligament - surgery
/ Anterior Cruciate Ligament Injuries - surgery
/ Clinical outcomes
/ Complete debridement
/ Debridement
/ Decompression
/ Degeneration
/ Humans
/ Knee
/ Knee Joint - surgery
/ Ligaments
/ Literature reviews
/ Management
/ Medicine
/ Medicine & Public Health
/ Mucoid degeneration
/ Orthopedics
/ Osteoarthritis
/ Osteoarthritis, Knee - surgery
/ Partial debridement
/ Patients
/ Range of motion
/ Reduction
/ Reduction plasty
/ Sports Medicine
/ Strategy
/ Systematic review
/ Treatment Outcome
2023
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Partial debridement is the most commonly reported treatment option for mucoid degeneration of the anterior cruciate ligament: a systematic review
by
Diao, Yi David
, Nagai, Kanto
, Kay, Jeffrey
, Hoshino, Yuichi
, de SA, Darren
, Vivekanantha, Prushoth
in
Anterior cruciate ligament
/ Anterior Cruciate Ligament - surgery
/ Anterior Cruciate Ligament Injuries - surgery
/ Clinical outcomes
/ Complete debridement
/ Debridement
/ Decompression
/ Degeneration
/ Humans
/ Knee
/ Knee Joint - surgery
/ Ligaments
/ Literature reviews
/ Management
/ Medicine
/ Medicine & Public Health
/ Mucoid degeneration
/ Orthopedics
/ Osteoarthritis
/ Osteoarthritis, Knee - surgery
/ Partial debridement
/ Patients
/ Range of motion
/ Reduction
/ Reduction plasty
/ Sports Medicine
/ Strategy
/ Systematic review
/ Treatment Outcome
2023
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Partial debridement is the most commonly reported treatment option for mucoid degeneration of the anterior cruciate ligament: a systematic review
by
Diao, Yi David
, Nagai, Kanto
, Kay, Jeffrey
, Hoshino, Yuichi
, de SA, Darren
, Vivekanantha, Prushoth
in
Anterior cruciate ligament
/ Anterior Cruciate Ligament - surgery
/ Anterior Cruciate Ligament Injuries - surgery
/ Clinical outcomes
/ Complete debridement
/ Debridement
/ Decompression
/ Degeneration
/ Humans
/ Knee
/ Knee Joint - surgery
/ Ligaments
/ Literature reviews
/ Management
/ Medicine
/ Medicine & Public Health
/ Mucoid degeneration
/ Orthopedics
/ Osteoarthritis
/ Osteoarthritis, Knee - surgery
/ Partial debridement
/ Patients
/ Range of motion
/ Reduction
/ Reduction plasty
/ Sports Medicine
/ Strategy
/ Systematic review
/ Treatment Outcome
2023
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Partial debridement is the most commonly reported treatment option for mucoid degeneration of the anterior cruciate ligament: a systematic review
Journal Article
Partial debridement is the most commonly reported treatment option for mucoid degeneration of the anterior cruciate ligament: a systematic review
2023
Request Book From Autostore
and Choose the Collection Method
Overview
Purpose
To determine clinical outcomes and risks of various management strategies for mucoid degeneration of the anterior cruciate ligament (MD-ACL).
Methods
Three databases MEDLINE, PubMed and EMBASE were searched from inception to January 29th, 2023 for literature outlining clinical outcomes for various management strategies of MD-ACL. The authors adhered to the PRISMA and R-AMSTAR guidelines as well as the Cochrane Handbook for Systematic Reviews of Interventions. Data on satisfaction scores, visual analogue scale (VAS) scores, Lysholm scores, International Knee Documentation Committee (IKDC) scores, Knee Osteoarthritis and Outcome Scores (KOOS), range of motion and Lachman test were recorded.
Results
A total of 14 studies comprising 776 patients (782 knees) were included in this review. Partial debridement was reported in ten (71.4%) studies comprising 446 patients, showing significant improvements in VAS, Lysholm, IKDC scores and range of motion. Complete debridement was reported by two (14.2%) studies comprising 250 patients, and resulted in increases in Lysholm scores, KOOS, and range of motion. Reduction plasty was reported in two (14.2%) studies comprising 26 patients and showed improvements in VAS and Lysholm scores, and range of motion. Other methods of treatment included conservative management and ultrasound decompression. Complete debridement resulted in 10/23 (43%) patients with a positive Lachman test. This was followed by reduction plasty and partial debridement, with 5/26 (19.2%) and 45/340 (13.2%) patients respectively having positive Lachman or elevated knee arthrometer scores. Pivot shifting was only reported in studies on partial debridement and reduction plasty, with 14/93 (15.1%) and 1/21 (4.8%) patients have positive results, respectively.
Conclusion
The most commonly reported management strategy for MD-ACL is partial debridement with complete debridement, reduction plasty and conservative management as alternative options. Current operative management strategies place individuals at risk for ACL insufficiency. Information from this review can aid surgeons and clinicians in understanding what treatment options are best for this patient population, by understanding the reported clinical benefits and risks of each strategy.
Level of evidence
IV.
Publisher
Springer Berlin Heidelberg,John Wiley & Sons, Inc
This website uses cookies to ensure you get the best experience on our website.